Tags Archives: rivaroxaban

thumbnail
0 comment

Reducir el riesgo de hemorragia perioperatoria en pacientes con ticagrelor / rivaroxaban

Terapia CytoSorb en Cirugía Cardíaca de urgencia y emergencia. CytoSorb reduce las complicaciones de hemorragia en pacientes de emergencia al eliminar de modo efectivo el ticagrelor y el rivaroxaban de..

Read More
thumbnail
0 comment

Use of CytoSorb in a patient with acute bleeding complications due to oral anticoagulation with rivaroxaban

This report describes the case of a 68-year-old patient (known medical history: untreated chronic obstructive pulmonary disease (COPD), ectopic atrial tachycardia, liver cirrhosis CHILD stage B, no contact with physicians..

Read More
thumbnail
0 comment

The effect of hemoadsorption on rivaroxaban blood plasma concentration in emergency cardiac surgery

Abstract Hemoadsorption was used in a 59-year-old patient with an acute type A aortic dissection, who was on rivaroxaban and dual antiplatelet therapy with clopidogrel and acetylsalicylic acid. Our aim..

Read More
thumbnail
0 comment

2020 Acute Coronary Syndromes (ACS) in Patients Presenting without Persistent ST-Segment Elevation (Management of).Guidelines

Preamble Guidelines summarize and evaluate available evidence with the aim of assisting health professionals in proposing the best management strategies for an individual patient with a given condition. Guidelines and..

Read More
thumbnail
0 comment

Direct oral anticoagulants and heparins: laboratory values and pitfalls in ‘bridging therapy’

Abstract OBJECTIVES:  The three direct oral anticoagulants (DOACs) dabigatran, apixaban and rivaroxaban are now widely used in clinical practice. For patients requiring perioperative interruption of DOACs, heparin bridging is still..

Read More
thumbnail
0 comment

Use of CytoSorb in elective mitral valve replacement and left atrial appendage occlusion with long-term rivaroxaban treatment

This case study reports on a 56-year-old female patient who presented at the Cardiac Center Aarau for elective mitral valve reconstruction/replacement and left atrial appendage occlusion, after she suffered cardiac..

Read More
thumbnail
0 comment

Ticagrelor and Rivaroxaban Elimination With CytoSorb Adsorber Before Urgent Off-Pump Coronary Bypass

This case reports on a 58-year-old male patient who was admitted to the South Munich Surgical Clinic for urgent coronary artery bypass surgery.   [pdf-embedder url="https://perfusfind.com/wp-content/uploads/2021/02/Ticagrelor-and-Rivaroxaban-Elimination-With-CytoSorb-Adsorber-Before-Urgent-Off-Pump-Coronary-Bypass-_compressed.pdf" title="Ticagrelor and Rivaroxaban Elimination..

Read More
thumbnail
0 comment

Reducir el riesgo de hemorragia perioperatoria en pacientes con ticagrelor / rivaroxaban

El uso intraoperatorio de CytoSorb en pacientes sometidos a tratamiento con ticagrelor o rivaroxaban que tienen que someterse a una cirugía de emergencia a corazón abierto es un método seguro..

Read More
thumbnail
0 comment

Reduce peri-operative bleeding risk in patients on ticagrelor/rivaroxaban

The intraoperative use of the CytoSorb hemoadsorption in patients with ticagrelor or rivaroxaban treatment undergoing emergency open-heart operations is a safe and effective method to reduce bleeding complications and to..

Read More
thumbnail
0 comment

Bleeding Complications After Use of Novel Oral Anticoagulants in Patients Undergoing Cardiac Surgery

Abstract Background The study was performed to analyze the results of  and bleeding complications after administration of novel  (NOAC). Methods We investigated 81 consecutive patients (median age 74 years, interquartile range [IQR]:..

Read More